Inovio Pharma (INO) Misses Q2 EPS by 61c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.13 +1.80%
EPS Growth %: +60.7%
Financial Fact:
Grant and miscellaneous revenue: 9.41M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +60.7%
Financial Fact:
Grant and miscellaneous revenue: 9.41M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.61).
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- MSCI upgrades Bulgaria to Frontier, flags Indonesia and Turkey risks
- U.S. presses Meta to agree to A.I. reviews as security concerns rise - NYT
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
